Table 2.

The number of patients with BRCA or HRD status in the included studies.

Author	Study	Year	No. of Patients				No. of Patients with pCR
			mBRCA+	WtBRCA	HRD+	HRD-	mBRCA+	WtBRCA	HRD+	HRD-
Fasching et al. [22]	GeparPLA	2020	20	16	27		12	6	16
Mayer et al. [23]	TBCRC030	2020	6	69	39	17	1	5	5	1
Yuan et al. [24]	NCT01525966	2020	11	44			8	20
Sharma et al. [25]	NeoSTOP	2020	17	65			13	32
Fontaine et al. [26]	BSMO	2019	9	42			7	22
Hahnen et al. [28], Loibl.S et al. [27]	GeparSixto	2017, 2018	26	120	74	27	17	66	48	11
Loibl et al. [29], Telli et al. [30]	BrighTNess	2018	70	406	225	104	38	222	138	42
Sella et al. [35]		2018	14	23			9	10
Sharma et al. [31]	PROGECT	2017	27	133			16	75
Connolly et al. [32]	TBCRC 008	2016			12	6			8	1
Telli et al. [33]	PrECOG 0105	2015	17	73	50	15	9	22	33	3
Kaklamani et al. [34]	NCT01372579	2015	3	27	12	14	2	11	9	2
Silver et al. [36]		2010	2	26			2	4

Abbreviations: HRD: homologous recombination deficiency; pCR: pathological complete response CR: complete response; mBRCA: mutated BRCA; WtBRCA: wildtype BRCA.